Literature DB >> 26637929

Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.

J William Lindsey1, Samantha L deGannes2, Kimberly A Pate2, Xiurong Zhao2.   

Abstract

Epstein-Barr virus (EBV) is associated with multiple sclerosis (MS), and antibodies to the EBV nuclear antigen-1 (EBNA-1) are consistently increased in MS patients. The hypothesis of this study is that anti-EBNA-1 antibodies cross-react with a self antigen in MS patients. We affinity purified anti-EBNA-1 antibodies from human plasma, used the anti-EBNA-1 to immunoprecipitate antigens from human brain, and identified bound antigens with mass spectrometry. Anti-EBNA-1 consistently bound heterogeneous nuclear ribonucleoprotein L (HNRNPL). We expressed both the long and short isoforms of this protein, and verified with Western blots and ELISA that the long isoform cross-reacts with EBNA-1. Immunohistochemistry demonstrated that anti-EBNA-1 bound to an antigen in the nucleus of cultured rat central nervous system cells. ELISA demonstrated the presence of antibodies to HNRNPL in the plasma of both healthy controls and MS patients, but anti-HNRNPL was not increased in MS patients. We conclude that HNRNPL is an autoantigen which cross-reacts with EBNA-1. The relevance of this autoantigen to MS and other autoimmune diseases remains to be investigated.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody cross-reactivity; Epstein-Barr virus; Molecular mimicry; Multiple sclerosis

Mesh:

Substances:

Year:  2015        PMID: 26637929      PMCID: PMC4698215          DOI: 10.1016/j.molimm.2015.11.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  38 in total

1.  Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.

Authors:  Gerald N DeLorenze; Kassandra L Munger; Evelyn T Lennette; Norman Orentreich; Joseph H Vogelman; Alberto Ascherio
Journal:  Arch Neurol       Date:  2006-04-10

2.  Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1.

Authors:  J H Vaughan; J R Valbracht; M D Nguyen; H H Handley; R S Smith; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

3.  The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.

Authors:  G H Rhodes; J R Valbracht; M D Nguyen; J H Vaughan
Journal:  J Autoimmun       Date:  1997-10       Impact factor: 7.094

4.  Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: implications for the pathogenesis of rheumatoid arthritis.

Authors:  P Birkenfeld; N Haratz; G Klein; D Sulitzeanu
Journal:  Clin Immunol Immunopathol       Date:  1990-01

5.  Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I.

Authors:  A Sabbatini; S Bombardieri; P Migliorini
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

6.  Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.

Authors:  M Esposito; V Venkatesh; L Otvos; Z Weng; S Vajda; K Banki; A Perl
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

7.  Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

Authors:  Krishnan Sundar; Sabine Jacques; Paul Gottlieb; Raquel Villars; Mary-Ellen Benito; Devon K Taylor; Linda A Spatz
Journal:  J Autoimmun       Date:  2004-09       Impact factor: 7.094

8.  An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway.

Authors:  J H Vaughan; T Riise; G H Rhodes; M D Nguyen; E Barrett-Connor; H Nyland
Journal:  J Neuroimmunol       Date:  1996-09       Impact factor: 3.478

9.  Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens.

Authors:  S J Yeaman; S P Fussey; D J Danner; O F James; D J Mutimer; M F Bassendine
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

10.  An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.

Authors:  P Sundström; P Juto; G Wadell; G Hallmans; A Svenningsson; L Nyström; J Dillner; L Forsgren
Journal:  Neurology       Date:  2004-06-22       Impact factor: 9.910

View more
  7 in total

1.  Atypical immune response to Epstein-Barr virus in major depressive disorder.

Authors:  Lorraine Jones-Brando; Faith Dickerson; Glen Ford; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Kevin Sweeney; Amalia Squire; Sunil Khushalani; Robert Yolken
Journal:  J Affect Disord       Date:  2019-11-30       Impact factor: 4.839

Review 2.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

Review 3.  cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.

Authors:  Patrick Vandormael; Patrick Verschueren; Liesbeth De Winter; Veerle Somers
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 4.  Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.

Authors:  Mario E Cruz-Muñoz; Ezequiel M Fuentes-Pananá
Journal:  Front Microbiol       Date:  2018-01-05       Impact factor: 5.640

Review 5.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

6.  Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.

Authors:  Ute-Christiane Meier; Richard Christopher Cipian; Abbas Karimi; Ranjan Ramasamy; Jaap Michiel Middeldorp
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

7.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections.

Authors:  Nuno Sepúlveda; Jorge Carneiro; Eliana Lacerda; Luis Nacul
Journal:  Front Immunol       Date:  2019-11-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.